Terrascent Stock Price, News & Analysis

TerrAscend (TSNDF) reported its Q1 2025 financial results with net revenue of $71.0 million, down 4.5% from Q4 2024 due to seasonality. The company achieved a gross profit margin of 51.8%, up 160 basis points from Q4 2024. Despite posting a GAAP net loss of $12.3 million, TerrAscend demonstrated strong operational performance with Adjusted EBITDA of $15.3 million (21.6% margin) and positive free cash flow of $5.5 million. The company maintained its leadership in New Jersey, improved market share in Maryland, and expanded operations through strategic acquisitions, including a new dispensary in Ohio and a pending acquisition in New Jersey. TerrAscend's strong balance sheet, with $29.4 million in cash, over $150 million in owned real estate, and no significant debt maturities until 2028, positions it well for future growth.

TerrAscend (TSNDF) has completed its acquisition of Ratio Cannabis LLC, a cannabis dispensary in Goshen Township, Ohio. This strategic move marks TerrAscend's entry into its sixth U.S. state and expands its retail footprint to 39 dispensaries across six U.S. states and Canada. The acquired dispensary generates $9 million in annualized revenue and enjoys a competitive advantage with no competition within a 20-mile radius.

The acquisition is expected to be immediately accretive to EBITDA and cashflow. TerrAscend plans to continue its expansion in Ohio through additional dispensary acquisitions, up to the state's limit of eight dispensaries.

TerrAscend (TSX: TSND) (OTCQX: TSNDF) has signed an agreement to acquire Union Chill Cannabis Company, a single dispensary operator in Hunterdon County, New Jersey. The acquisition, pending regulatory approval, will mark TerrAscend's fourth dispensary in New Jersey. Union Chill generates over $11 million in annualized revenue and is expected to be immediately accretive to TerrAscend's EBITDA and cashflow.

The strategic acquisition will allow TerrAscend to introduce its premium brand portfolio, including Kind Tree, Legend, Valhalla, Cookies, and Wana. The company plans to sign multiple additional transactions in New Jersey by the end of 2025 and is expanding its cultivation and manufacturing capacity at its Boonton facility. Post-acquisition, TerrAscend's retail footprint will expand to 39 dispensaries across five U.S. states and Canada.

TerrAscend (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, has scheduled its first quarter 2025 earnings conference call for Thursday, May 8, 2025 at 5:00 p.m. Eastern Time. The company will release its Q1 2025 financial results after market close on the same day.

The earnings call will be accessible via webcast and telephone dial-in, with replay options available until May 22, 2025. Investors and interested parties can join through the webcast link or by calling 1-888-510-2154, with replay access through 1-289-819-1450 or 1-888-660-6345 using entry code 76466#.

TerrAscend (TSNDF) reported its Q4 and full year 2024 financial results, with Q4 net revenue reaching $74.4 million, a slight increase of 0.3% from Q3. The company achieved a gross profit margin of 50.2% in Q4, up 140 basis points from Q3.

For full year 2024, net revenue was $306.7 million, down 3.3% from 2023, with an adjusted EBITDA of $60.7 million. The company maintained positive cash flow for the 10th consecutive quarter, generating $38 million in operating cash flow and $28.6 million in free cash flow for 2024.

Notable highlights include:

• Maintained #1 market share position in New Jersey throughout 2024
• Improved Maryland operations from negligible revenue to $70 million Q4 run rate
• Recorded Q4 GAAP net loss of $30.2 million, including $45.4 million non-cash impairment charge related to Michigan business
• Completed non-dilutive debt financing, extending majority of debt maturities to 2028
• Initiated first-ever share repurchase program in August 2024

TerrAscend announced preliminary Q4 2024 financial results, reporting net revenue of $74.4 million, a slight increase of 0.3% from Q3 2024's $74.2 million. The company achieved a gross profit margin of 50.2%, up 140 basis points from Q3, while reducing general and administrative expenses and generating positive cashflow from operations.

The company maintained its #1 market share position in New Jersey throughout 2024 and saw consecutive quarterly revenue growth in Maryland with gross margins exceeding 50%. TerrAscend is preparing for potential adult-use implementation in Pennsylvania, where it operates a 150k sq ft cultivation facility. The company is also expanding into Ohio through the Ratio Cannabis deal, marking its entry into a sixth state.

TerrAscend has appointed Lynn Gefen as Chief People Officer, expanding her current role as Chief Legal Officer and Corporate Secretary, effective November 12, 2024. This consolidation aligns with the company's strategy to streamline operations and optimize resources. Gefen, who joined TerrAscend in May 2022, brings extensive experience from previous roles at HomeServe, Diageo North America, and Citrix Systems, where she handled various legal, compliance, and corporate matters. She holds a J.D. from American University and a Bachelor of Arts from the University of Florida.

TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF) reported Q3 2024 financial results with net revenue of $74.2 million, down from $77.5 million in Q2 2024. The company maintained a gross profit margin of 48.8% and reported a net loss of $21.4 million from continuing operations. Notable achievements include the ninth consecutive quarter of positive cash flow from operations and fifth consecutive quarter of positive free cash flow. The company secured a $140 million senior secured term loan at 12.75% interest and announced plans to enter the Ohio market through a dispensary acquisition. TerrAscend maintains the #1 market share position in New Jersey and grew wholesale revenue in Maryland by 26% quarter-over-quarter.

TerrAscend has signed a definitive agreement to acquire Ratio Cannabis , a profitable dispensary in Goshen Township, Ohio, marking its entry into its sixth state. The $10.3 million acquisition includes $5.0 million in cash, $1.32 million in company shares, and a $3.98 million seller's note. The transaction is expected to be immediately accretive on EBITDA and cashflow. Ratio Cannabis operates in a strategic location with no competition within a 20-mile radius. This acquisition will expand TerrAscend's U.S. retail footprint to 38 dispensaries across six states, with plans for further expansion in Ohio's emerging adult-use market.